The University of Chicago Header Logo

Connection

David T. Rubin to Biosimilar Pharmaceuticals

Back to Details
This is a "connection" page, showing publications David T. Rubin has written about Biosimilar Pharmaceuticals.
David T. Rubin
Connection Strength
0.356
Biosimilar Pharmaceuticals
  1. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116.
    View in: PubMed
    Score: 0.186
  2. The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know? Gastrointest Endosc Clin N Am. 2019 Jul; 29(3):405-419.
    View in: PubMed
    Score: 0.170
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.